ArticlePloS one2025
The pursuit of novel head and neck cancer biomarkers - tissue and blood expression of chloride intracellular channels family.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe chloride intracellular channels (CLICs) engage in cancer pathogenesis and have been considered various cancer biomarkers and therapeutic targets. Preliminary research suggests CLICs may be important players in head and neck squamous cell carcinoma (HNSCC). There is a need for reliable HNSCC biomarkers besides well-known HPV and PD-L1.
aimThe study aimed to assess the role of CLICs in HNSCC pathogenesis and as potential disease biomarkers.
methodsWe compared the CLIC1-CLIC6 genes expression between the HNSCC tumors (n = 99) and the tissue from the free surgical margin (n = 74) at the mRNA level with RT-qPCR and at the protein level with Western Blot. To investigate the role of CLIC1-CLIC6 proteins as potential HNSCC blood biomarkers, we performed the ELISA assays on blood serum from 38 HNSCC patients and eight healthy individuals.
resultsWe found significant differences in the expression of every analyzed CLIC. At the mRNA level, CLIC1 and CLIC4 were overexpressed in oral cancer tissue, CLIC3, CLIC5, and CLIC6 were down-expressed; in laryngeal cancer tissue, CLIC2 and CLIC3 were down-expressed. Tumor staging impacted CLIC1 and CLIC6 tissue expression, and histological grade impacted CLIC6 tissue expression. At the protein level, CLIC3 was down-expressed in oral cancer tissue. Furthermore, CLIC1 and CLIC3 proteins were overexpressed, and CLIC4 and CLIC6 were down-expressed in the oral cancer patients' blood serum compared to the control group.
conclusionThe different expression patterns of CLICs in HNSCC patients' tissues and blood serum suggest that they may play an essential role in HNSCC pathogenesis and serve as biomarkers for HNSCC detection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.